CTRX, STJ, CI, TMO And BAX, Pushing Health Services Industry Downward

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 3 points (0.0%) at 15,304 as of Thursday, May 23, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 979 issues advancing vs. 1,985 declining with 110 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is down 0.37. On the negative front, top decliners within the industry include Agilent Technologies ( A), down 1.34, and Varian Medical Systems ( VAR), down 1.29.

TheStreet Ratings group would like to highlight 5 stocks pushing the industry lower today:

5. Catamaran ( CTRX) is one of the companies pushing the Health Services industry lower today. As of noon trading, Catamaran is down $0.67 (-1.4%) to $47.90 on average volume Thus far, 973,000 shares of Catamaran exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $47.51-$48.25 after having opened the day at $48.17 as compared to the previous trading day's close of $48.57.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $10.4 billion and is part of the health care sector. The company has a P/E ratio of 68.1, above the S&P 500 P/E ratio of 17.7. Shares are up 7.0% year to date as of the close of trading on Wednesday.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, compelling growth in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Catamaran Ratings Report now.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.

If you liked this article you might like

As Cyberattacks Rise, This Is Why CEOs Might Want to Prepare for the Worst and Buy Bitcoins

The Price of Bitcoin May Be Rising Because of This One Factor

Crude Surge Marches Dow to Near Record Close

Analysts' Actions -- Cirrus Logic, Ford, Kinder Morgan, PayPal and More

Verizon Nixing Discounted Phones May Turn Into a Self-Inflicted Wound